Blog Category

Partnering

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE

, ,

/

3 August 2026

Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics

,

/

12 March 2026

Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia

, ,

/

28 January 2026

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia

,

/

13 October 2025

Biophytis Secures public funding in Brazil for Obesity Phase 2 Trial and Signs Agreements with Leading local Clinical Partners

,

/

15 September 2025

Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for Sarcopenia

,

/

15 July 2025

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China

, , ,

/

21 January 2025

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101

, , ,

/

14 January 2025

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia

,

/

22 July 2024

Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens

,

/

12 June 2024

Biophytis and the University of Liège explore the potential of Sarconeos (BIO101) in the treatment of viral respiratory failure

,

/

4 December 2023

Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)

,

/

25 September 2023